The Maryland Life Sciences Advisory Board (LSAB) today announced a series of strategic recommendations to grow Maryland’s biohealth industry and position the state as a globally recognized Top 3 U.S. BioHealth Innovation Hub by 2023. Maryland is currently one of the most asset-rich states for biohealth in the nation, and is home to top federal agencies, like the National Institutes for Health, the U.S. Food and Drug Administration, and the National Cancer Institute; key federal research labs and world-class higher education institutions; and a confluence of more than 500 biohealth companies.